Navigation Links
QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
Date:3/31/2017

HILDEN, Germany and GERMANTOWN, Maryland, March 31, 2017 /PRNewswire/ --

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer. QIAGEN has acquired an exclusive worldwide license from Johns Hopkins University for detecting the AR-V7 biomarker in all sample and cell types through nucleic acid tests such as polymerase chain reaction (PCR) or next-generation sequencing (NGS). Johns Hopkins researchers have used AdnaTest technology in studies to evaluate the expression of AR-V7 messenger RNA in prostate cancer patients.

"Our AdnaTest workflow unlocks an important biomarker for clinical research to provide for the development of prostate cancer diagnostics in the future. Providing accurate insights from circulating tumor cells in a blood sample, our AR-V7 solution is a significant addition to our portfolio of non-invasive liquid biopsies for Personalized Healthcare," said Thierry Bernard, Senior Vice President and Head of QIAGEN's Molecular Diagnostics Business Area. "We are pleased to partner with the pioneering researchers at Johns Hopkins in developing this workflow. We plan to make the AdnaTest kit commercially available this year, as a Sample to Insight solution for clinical researchers."

Click here for the full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={55C014E9-91D1-4E5E-8FF0-822B2224081A}&lang=en

Contacts: 

QIAGEN 

Investor Relations            
John Gilardi    
+49-2103-29-11711        
e-mail: ir@QIAGEN.com             
           
Public Relations
Dr. Thomas Theuringer
+49-2103-29-11826  
e-mail: pr@QIAGEN.com


'/>"/>
SOURCE QIAGEN N.V.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
2. New Study Published in Lancet Respiratory Medicine Highlights QIAGENs QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants
3. QIAGENs QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits
4. How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta
5. QIAGEN Enhances Bioinformatics Portfolio with Acquisition of OmicSoft
6. QIAGEN Announces Comprehensive Range of Enhancements for GeneReader NGS System
7. Research and Markets - Global Cervical Cancer Diagnostic Testing Market Growth of 6%, 2016-2020 with Becton, Hologic & Qiagen Dominating
8. Research Reports Coverage on Services Stocks -- Myriad Genetics, Qiagen, INC Research, and La Quinta
9. QIAGEN GeneReader NGS System to Relaunch in U.S. Market
10. QIAGENs GeneReader NGS System Streamlines Data Management for Labs
11. QIAGEN führt Flüssigbiopsie-Workflow für das GeneReader NGS-System ein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2018)... ... August 07, 2018 , ... ... appointment of Richard A. Stark to assume the role of Sanarus Technologies President, effective immediately. ... years of strategic development, marketing and sales experience in medical device toward finding new ...
(Date:8/3/2018)... ... ... In order to improve safety for everyone throughout the summer, personal injury ... risks of injury that many amusement park rides present during the summer months. ... thrilling ride on a roller coaster. Unfortunately, these fun times can quickly turn dangerous ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... gummy smile for custom crown lengthening treatment at his Eden Prairie, ... line and an unsteady self-conscious. Using decades of experience, Dr. Sanchez is excited ...
Breaking Medicine Technology:
(Date:8/9/2018)... ... August 09, 2018 , ... ... engaged as an Operating Partner and will have an exclusive relationship with the ... in the firm’s strategic planning, human capital sourcing, and deal origination, evaluation and ...
(Date:8/7/2018)... ... August 07, 2018 , ... The American Psychiatric ... to receive the 2018 Board of Directors Student Scholarship . The APNA ... psychiatric-mental health nursing and develop the next generation of leaders in the profession. ...
(Date:8/2/2018)... ... 2018 , ... Dr. Srini Pillay , best-selling author of TINKER ... could care less, demonstrating a “whatever” attitude toward life, people, and situations around them. ... often overlooked reason relates to being overworked. Called self-regulation depletion (SRD), this condition occurs ...
(Date:8/2/2018)... ... August 02, 2018 , ... A ... of topics in acute pain management. In The Role of Acute Care in ... Prescribing Engagement Network—an innovative approach to the opioid epidemic launched in the state ...
(Date:8/2/2018)... ... August 02, 2018 , ... Tunstall Americas has launched their ... can partner with Tunstall Americas for After-hours call-handling, Overflow call-handling, and Appointment Scheduling ... expand their suite of Patient Access Solutions, and gives their existing and new ...
Breaking Medicine News(10 mins):